DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 236 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2022. The put-call ratio across all filers is 1.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $799,973 | +13.2% | 54,162 | -1.0% | 0.02% | +13.3% |
| Q2 2023 | $706,621 | -45.8% | 54,692 | -58.9% | 0.02% | -53.1% |
| Q1 2023 | $1,303,906 | -49.4% | 132,916 | -45.2% | 0.03% | -56.2% |
| Q4 2022 | $2,579,008 | +46.7% | 242,388 | +43.9% | 0.07% | +37.7% |
| Q3 2022 | $1,758,000 | +138.2% | 168,412 | +187.4% | 0.05% | +120.8% |
| Q2 2022 | $738,000 | -22.7% | 58,602 | -33.5% | 0.02% | -20.0% |
| Q1 2022 | $955,000 | +58.6% | 88,131 | +106.0% | 0.03% | +57.9% |
| Q4 2021 | $602,000 | -38.6% | 42,788 | -16.1% | 0.02% | -52.5% |
| Q3 2021 | $980,000 | – | 50,992 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 11,771,708 | $115,951,000 | 7.60% |
| Chicago Capital, LLC | 5,878,959 | $57,908,000 | 2.26% |
| PFM Health Sciences, LP | 2,990,770 | $29,459,000 | 0.92% |
| Avidity Partners Management LP | 3,400,000 | $33,490,000 | 0.90% |
| MIZUHO MARKETS AMERICAS LLC | 617,358 | $6,081,000 | 0.72% |
| Rhenman & Partners Asset Management AB | 750,000 | $7,388,000 | 0.50% |
| Jackson Creek Investment Advisors LLC | 115,333 | $1,136,000 | 0.42% |
| Rock Springs Capital Management LP | 1,679,921 | $16,547,000 | 0.33% |
| FEDERATED HERMES, INC. | 14,243,800 | $140,301,000 | 0.26% |
| JACKSON SQUARE CAPITAL, LLC | 80,400 | $792,000 | 0.25% |